Frontier Zdravlje

For over 70 years, Frontier Zdravlje has been committed to improving health outcomes through quality, innovation, and trust. Every product we develop and every partnership we build is focused on creating long-term value and a healthier future.

We work closely with our partners to bring ideas to life, combining pharmaceutical expertise, operational agility, and regulatory discipline to navigate complex markets and deliver reliable solutions.

Since April 1st, 2021, Zdravlje has operated as an independent pharmaceutical company under the ownership of Frontier Pharma and Baystone Group, UK-based investors with deep industry experience.

Based in Leskovac, Serbia, Frontier Zdravlje runs EU-GMP approved manufacturing facilities supplying around 40 countries worldwide. With more than 350 employees and an annual output of 1.7 billion units, we support partners across the EU, UK, North America, Latin America, Asia Pacific, and Africa.